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A 53-year-old man presented with two months of fatigueand dyspnea on exertion, and was found to have
hepatomegaly and hypotension (71/30 mmHg). Initial tests
showed lactic acidosis with normal cardiac enzymes.
Computed tomography of the abdomen revealed diffuse,
hypodense, hepatic lesions without ischemic bowels. Short-
ly after admission, he developed cardiopulmonary arrest
with ventricular fibrillation and expired despite aggressive
medical support. Postmortem examination demonstrated
dilated cardiomyopathy without coronary artherosclerosis
(heart weight 785 g, normal 365±71 g) and hepatomegaly
with diffuse hemangiomatosis (liver weight 4,455 g, normal
1,677±396 g, Fig. 1).1
Diffuse hepatic hemangiomatosis is extremely rare.2 The
histologic characteristics include dilated vascular channels
lined with flat endothelial cells (Fig. 2). The etiologies are
poorly understood, though its association with the use of
estrogen and metoclopramide has been described.3,4 The two
most common causes of death are cardiomyopathy (from
massive hepatic arteriovenous shunting) and cirrhosis.5
Surgical resection is an option in selected cases with small
lesions without cirrhosis.5,6 Most cases are inoperable because
of poor delineation of the tumor border and bleeding risk.
Other anecdotal therapies include hepatic artery ligation and
radiation.6 Prognosis depends on the area of hepatic involve-
ment and cardiac function.
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Figure 1. Multiple irregular, well-circumscribed, dark brown
lesions (arrow) were seen in the liver parenchyma. The lesions
ranged from 0.5-10 cm in greatest dimension.
Figure 2. Microscopic examination revealed cavernous vascular
spaces (asterisk) separated by thin fibrous septae lined by
endothelial cells (arrow). These findings confirmed the diag-
nosis of hepatic hemangiomatosis.
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